EDGAR Filing Documents for 0001358403-15-000033

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001358403-15-000033

Filing Date

2015-06-19

Accepted

2015-06-19 17:06:08

Documents

Period of Report

2015-06-16

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4/A	wf-form4a_143474795838162.html	4/A
1	FORM 4/A	wf-form4a_143474795838162.xml	4/A	6109
	Complete submission text file	0001358403-15-000033.txt		7632

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030

Business Address

Type: 4/A | Act: 34 | File No.: 001-36783 | Film No.: 15943026